Search Results - "Osborne, Stuart"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    The use of a pre-operative scoring system for the prediction of phacoemulsification case difficulty and the selection of appropriate cases to be performed by trainees by Osborne, Stuart A, Severn, Phillip, Bunce, Catey V, Fraser, Scott G

    Published in BMC ophthalmology (27-12-2006)
    “…To establish whether a previously validated scoring system (Habib) for the prediction of risk or likelihood of posterior capsule rupture during…”
    Get full text
    Journal Article
  7. 7

    Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma by Lukas, Rimas V., Rodon, Jordi, Becker, Kevin, Wong, Eric T., Shih, Kent, Touat, Mehdi, Fassò, Marcella, Osborne, Stuart, Molinero, Luciana, O’Hear, Carol, Grossman, William, Baehring, Joachim

    Published in Journal of neuro-oncology (01-11-2018)
    “…Purpose Glioblastoma is the most common primary malignant brain tumor. No standard treatment exists for recurrent disease. Glioblastoma is associated with an…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Pharmacokinetics of pimecrolimus, a novel nonsteroid anti-inflammatory drug, after single and multiple Oral administration by SCOTT, Graham, OSBORNE, Stuart A, GREIG, Gerard, HARTMANN, Stefan, EBELIN, Marie-Eve, BURTIN, Pascale, RAPPERSBERGER, Klemens, KOMAR, Michael, WOLFF, Klaus

    Published in Clinical pharmacokinetics (01-01-2003)
    “…To investigate the pharmacokinetics and tolerability of the new nonsteroid anti-inflammatory pimecrolimus (SDZ ASM 981, Elidel) after oral administration. A…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer by Loupakis, Fotios, Hurwitz, Herbert I., Saltz, Leonard, Arnold, Dirk, Grothey, Axel, Nguyen, Quynh Lan, Osborne, Stuart, Talbot, Jonathan, Srock, Stefanie, Lenz, Heinz-Josef

    Published in British journal of cancer (11-12-2018)
    “…Background Two first-line (1L) bevacizumab trials showed the prognostic value of primary tumour location in metastatic colorectal cancer (mCRC). In this…”
    Get full text
    Journal Article
  12. 12

    Abstract PS11-28: Efficacy and safety of entrectinib in NTRK fusion-positive ( NTRK -fp) breast cancer by Lu, Janice, Blakely, Collin M., Le Tourneau, Christophe, Waqar, Saiama N., Bauer, Todd M., de Braud, Filippo, Hong, David S., Spira, Alexander, Tan, Tira, McCallum, Samuel, Osborne, Stuart, Simmons, Brian, Barve, Minal

    Published in Cancer research (Chicago, Ill.) (15-02-2021)
    “…Abstract Neurotrophic tyrosine receptor kinase genes (NTRK1/2/3) act as oncogenic drivers across a range of tumors. NTRK fusions occur at low frequency (<5%)…”
    Get full text
    Journal Article
  13. 13

    Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial by Gligorov, Joseph, Curigliano, Giuseppe, Müller, Volkmar, Knoop, Ann, Jenkins, Valerie, Verma, Sunil, Osborne, Stuart, Lauer, Sabine, Machackova, Zuzana, Fallowfield, Lesley, Pivot, Xavier

    Published in Breast (Edinburgh) (01-08-2017)
    “…Abstract Aim To assess the safety and tolerability of switching between subcutaneous (SC) and intravenous (IV) trastuzumab in the PrefHer study (NCT01401166)…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Prefmab: Final Analysis of Patient Preference for Subcutaneous Versus Intravenous Rituximab in Previously Untreated CD20+ Diffuse Large B-Cell Lymphoma and Follicular Lymphoma by Rummel, Mathias, Kim, Tae Min, Plenteda, Caterina, Capochiani, Enrico, Mendoza, Maria, Smith, Rodney, Osborne, Stuart, Grigg, Andrew

    Published in Blood (03-12-2015)
    “…Background Rituximab in combination with chemotherapy is the standard of care for patients with diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20